Telix Pharmaceuticals Limited (TLX)

Last Closing Price: 16.99 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Telix Pharmaceuticals Limited (TLX) had Net Income of $32.93M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$516.68M
Net Income
$32.93M
$180.45M
$336.23M
$462.50M
$54.18M
$-17.20M
$36.98M
$36.98M
$32.93M
$32.93M
$32.93M
$32.93M
$54.18M
$59.47M
331.23M
345.19M
$0.10
$0.10
Balance Sheet Financials
$605.98M
$29.65M
$394.41M
$1.00B
$218.30M
$369.41M
$407.24M
$625.54M
$374.85M
$100.33M
$374.85M
334.73M
Cash Flow Statement Financials
$28.39M
$-89.17M
$421.50M
$81.30M
$468.62M
$387.32M
$12.97M
--
--
Fundamental Metrics & Ratios
2.78
--
--
0.50
1.02
65.08%
10.49%
10.49%
11.51%
7.16%
6.37%
$18.94M
--
--
--
0.52
7.17
5.62
64.99
8.79%
32.82%
3.29%
4.42%
$1.12
$0.05
$0.08